Cargando…
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
Treatment of neurodegenerative diseases has become one of the most challenging topics of the last decades due to their prevalence and increasing societal cost. The crucial point of the non-invasive therapeutic strategy for neurological disorder treatment relies on the drugs’ passage through the bloo...
Autores principales: | Cunha, Anthony, Gaubert, Alexandra, Latxague, Laurent, Dehay, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309027/ https://www.ncbi.nlm.nih.gov/pubmed/34371733 http://dx.doi.org/10.3390/pharmaceutics13071042 |
Ejemplares similares
-
Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study
por: Cunha, Anthony, et al.
Publicado: (2022) -
Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment
por: Aghaei Delche, Nasim, et al.
Publicado: (2023) -
Recent Advances in the Chemistry of Glycoconjugate Amphiphiles
por: Latxague, Laurent, et al.
Publicado: (2018) -
Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications
por: Bose, Rajendran JC, et al.
Publicado: (2016) -
Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases
por: Patel, Chirag, et al.
Publicado: (2023)